NCT01227395View on ClinicalTrials.gov

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

CompletedOBSERVATIONAL

Enrollment

476

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

HIV Infection

Interventions

DRUG

Azithromycin

"Inhibition of onset: Perorally administer 1200mg of azithromycin (potency) once a week to adults.~Treatment: Perorally administer 600mg of azithromycin (potency) once a day to adults."